Q1 2023 Holdings
Filed 2023-05-15 | 47 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $154.4M | 226,770 | 10.2% |
| Salesforce.com, Inc.(CRM) | COM | 79466L302 | $115.6M | 578,500 | 7.6% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $112.9M | 3,940,413 | 7.4% |
| Brookfield Asset Mgmt Inc | CL A LTD VT SH | 112585104 | $82.1M | 2,508,830 | 5.4% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $73.2M | 3,377,768 | 4.8% |
| Taiwan Semiconductor MFG LTD(TSM) | SPONSORED ADS | 874039100 | $66.1M | 710,780 | 4.4% |
| Cable One Inc(CABO) | COM | 12685J105 | $66.1M | 94,103 | 4.4% |
| Lanzatech Global Inc | COM | 51655R101 | $61.4M | 15,814,845 | 4.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $54.7M | 832,878 | 3.6% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $51.2M | 500,827 | 3.4% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $49.6M | 2,340,772 | 3.3% |
| Apple Inc(AAPL) | COM | 037833100 | $48.7M | 295,280 | 3.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $40.5M | 6,071,703 | 2.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $40.5M | 1,684,193 | 2.7% |
| Arcellx, Inc.(ACLX) | COMMON STOCK | 03940C100 | $37.7M | 1,225,000 | 2.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $35.7M | 367,380 | 2.4% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $30.7M | 3,610,461 | 2.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $27.9M | 745,000 | 1.8% |
| Seagen Inc.(SGENUSD) | COM | 81181C104 | $27.3M | 134,986 | 1.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.7M | 118,383 | 1.6% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $23.2M | 2,095,900 | 1.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $22.8M | 1,339,304 | 1.5% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $20.5M | 3,430,377 | 1.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $20.2M | 448,804 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $17.7M | 1,100,000 | 1.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $17.3M | 1,200,000 | 1.1% |
| Dice Therapeutics, Inc. | COM | 23345J104 | $16.7M | 536,100 | 1.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $15.8M | 920,000 | 1.0% |
| Bellus Health Inc.(BLU) | COM NEW | 07987C204 | $15.4M | 2,137,975 | 1.0% |
| Spruce Biosciences Inc | COM | 85209E109 | $14.9M | 6,722,336 | 1.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $14.0M | 60,000 | 0.9% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $13.6M | 540,000 | 0.9% |
| Rallybio Corp | COM | 75120L100 | $13.0M | 2,270,110 | 0.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $12.0M | 700,000 | 0.8% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $11.1M | 180,000 | 0.7% |
| Silk RD MED Inc | COM | 82710M100 | $10.8M | 275,511 | 0.7% |
| Pharvaris N V(PHVS) | COM | N69605108 | $10.7M | 1,329,325 | 0.7% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $8.5M | 1,126,915 | 0.6% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $6.3M | 2,459,021 | 0.4% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $6.1M | 3,277,932 | 0.4% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $5.7M | 510,555 | 0.4% |
| Kinnate Biopharma Inc | COM | 49705R105 | $5.1M | 815,707 | 0.3% |
| Lava Therapeutics NV | SHS | N51517105 | $5.1M | 3,070,558 | 0.3% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $5.0M | 2,497,791 | 0.3% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $2.0M | 441,558 | 0.1% |
| Kezar Life Sciences Inc | COM | 49372L100 | $1.5M | 465,604 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $679.9K | 468,902 | 0.0% |